Charles Schwab Investment Management Inc. Cuts Stake in Vital Farms, Inc. $VITL

Key Points

• Charles Schwab Investment Management Inc. decreased its stake in Vital Farms, Inc. by 14.5%, owning 253,543 shares after selling 42,873 shares during the first quarter, which is valued at approximately $7.73 million.
• Vital Farms reported a 25.4% increase in revenue year-over-year for the latest quarter, with earnings per share of $0.36, surpassing the consensus estimate of $0.27.
• Insiders at Vital Farms have sold 103,901 shares of company stock recently, indicating a notable decrease in their ownership stakes.

Charles Schwab Investment Management Inc. reduced its position in Vital Farms, Inc. (NASDAQ:VITL - Free Report) by 14.5% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 253,543 shares of the company's stock after selling 42,873 shares during the period. Charles Schwab Investment Management Inc. owned 0.57% of Vital Farms worth $7,725,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. US Bancorp DE grew its stake in shares of Vital Farms by 36.2% during the first quarter. US Bancorp DE now owns 1,929 shares of the company's stock valued at $59,000 after buying an additional 513 shares during the last quarter. CWM LLC lifted its holdings in Vital Farms by 43.2% during the first quarter. CWM LLC now owns 2,154 shares of the company's stock worth $66,000 after buying an additional 650 shares during the period. Union Bancaire Privee UBP SA purchased a new stake in Vital Farms during the first quarter worth $112,000. Hanson & Doremus Investment Management purchased a new stake in Vital Farms during the first quarter worth $130,000. Finally, Guggenheim Capital LLC purchased a new stake in Vital Farms during the fourth quarter worth $207,000. 98.59% of the stock is currently owned by hedge funds and other institutional investors.

Vital Farms Stock Down 0.9%

VITL stock opened at $51.23 on Wednesday. The firm has a market cap of $2.29 billion, a PE ratio of 45.74 and a beta of 0.94. The company has a debt-to-equity ratio of 0.02, a quick ratio of 2.10 and a current ratio of 2.48. The firm's 50 day moving average price is $40.57 and its 200-day moving average price is $35.54. Vital Farms, Inc. has a one year low of $27.91 and a one year high of $52.63.

Vital Farms (NASDAQ:VITL - Get Free Report) last posted its earnings results on Thursday, August 7th. The company reported $0.36 earnings per share for the quarter, beating the consensus estimate of $0.27 by $0.09. The firm had revenue of $184.77 million during the quarter, compared to the consensus estimate of $170.28 million. Vital Farms had a net margin of 7.84% and a return on equity of 18.40%. The firm's revenue for the quarter was up 25.4% on a year-over-year basis. During the same quarter last year, the firm earned $0.36 EPS. Vital Farms has set its FY 2025 guidance at EPS. On average, equities research analysts anticipate that Vital Farms, Inc. will post 1.11 EPS for the current year.

Insider Buying and Selling at Vital Farms

In other news, SVP Stephanie Coon sold 10,005 shares of the company's stock in a transaction dated Tuesday, August 12th. The shares were sold at an average price of $46.15, for a total value of $461,730.75. Following the completion of the sale, the senior vice president directly owned 45,779 shares of the company's stock, valued at approximately $2,112,700.85. This represents a 17.94% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Thilo Wrede sold 1,200 shares of the company's stock in a transaction dated Friday, July 11th. The shares were sold at an average price of $38.97, for a total transaction of $46,764.00. Following the completion of the sale, the chief financial officer directly owned 56,187 shares of the company's stock, valued at $2,189,607.39. The trade was a 2.09% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 103,901 shares of company stock worth $4,141,052. 21.30% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

VITL has been the subject of several analyst reports. Stifel Nicolaus increased their price objective on Vital Farms from $44.00 to $48.00 and gave the company a "buy" rating in a report on Friday, August 8th. BMO Capital Markets reaffirmed an "outperform" rating on shares of Vital Farms in a research report on Friday, August 8th. Telsey Advisory Group increased their price target on Vital Farms from $46.00 to $50.00 and gave the stock an "outperform" rating in a research report on Friday, August 8th. Mizuho increased their price target on Vital Farms from $45.00 to $53.00 and gave the stock an "outperform" rating in a research report on Monday, August 11th. Finally, DA Davidson increased their price target on Vital Farms from $51.00 to $52.00 and gave the stock a "buy" rating in a research report on Monday, August 11th. Eleven research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, Vital Farms currently has a consensus rating of "Buy" and a consensus price target of $48.20.

Vital Farms Profile

Vital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.

Want to see what other hedge funds are holding VITL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Vital Farms, Inc. (NASDAQ:VITL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.